!– Global site tag (gtag.js) – Google Analytics –>Skip Navigation
TargetCancer Foundation promotes the development of lifesaving treatment protocols for rare cancers. TargetCancer Foundation directly supports initiatives at the forefront of cancer treatment by funding innovative research, fostering collaborations, and raising awareness among scientists, clinicians, and patients.
Since being founded by a patient with cholangiocarcinoma in 2009, TargetCancer Foundation has accelerated rare cancer research through millions in research funding grants, innovative scientific meetings, and other targeted initiatives. Through the TCF-001 TRACK clinical trial, TargetCancer Foundation is directly impacting patients facing rare cancers today by providing them with personalized information to potentially inform treatments while simultaneously generating critical data to drive rare cancer research forward.